Joseph C. Galante - 17 Mar 2025 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Director
Signature
Joseph C. Galante /s/ John Hamm as attorney -in-fact
Issuer symbol
CPIX
Transactions as of
17 Mar 2025
Net transactions value
+$5,170
Form type
4
Filing time
18 Mar 2025, 17:13:31 UTC
Previous filing
30 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Award $5,170 +1,000 +1.6% $5.17 61,856 17 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock award will vest 100% on March 17, 2026.